COCP
NASDAQ · Pharmaceuticals
Cocrystal Pharma Inc
$1.03
-0.06 (-5.50%)
Open$1.09
Previous Close$1.09
Day High$1.11
Day Low$1.03
52W High$2.67
52W Low$0.86
Volume—
Avg Volume48.5K
Market Cap15.02M
P/E Ratio—
EPS$-0.94
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+2,610.7% upside
Current
$1.03
$1.03
Target
$27.92
$27.92
$19.61
$27.92 avg
$38.36
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.74M | 2.80M | 3.00M |
| Net Income | 504.5K | 668.5K | 544.9K |
| Profit Margin | 18.4% | 23.9% | 18.1% |
| EBITDA | 921.2K | 997.7K | 969.2K |
| Free Cash Flow | 728.8K | 746.2K | 561.0K |
| Rev Growth | +19.3% | -9.2% | +14.0% |
| Debt/Equity | 0.92 | 0.92 | 0.80 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |